Skip to main content
SpringerLink
Log in

Congenital disorders of glycosylation (CDG): It's all in it!

  • Published:
Journal of Inherited Metabolic Disease

Abstract

Summary: Congenital disorders of glycosylation (CDGs) are due to defects in the synthesis of the glycan moiety of glycoproteins or other glycoconjugates. This review is devoted mainly to the clinical aspects of protein glycosylation defects. There are two main types of protein glycosylation: N-glycosylation and O-glycosylation. N-glycosylation generally consists of an assembly pathway (in cytosol and endoplasmic reticulum) and a processing pathway (in endoplasmic reticulum and Golgi). O-glycosylation lacks a processing pathway but is otherwise more complex. Sixteen disease-causing defects are known in protein glycosylation: 12 in N-glycosylation and four in O-glycosylation. The N-glycosylation defects comprise eight assembly defects (CDG-I) designated CDG-Ia to CDG-Ih, and four processing defects (CDG-II) designated CDG-IIa to CDG-IId. By far the most frequent is CDG-Ia (phosphomannomutase-2 deficiency). It affects the nervous system and many other organs. Its clinical expression varies from extremely severe to very mild (and thus probably underdiagnosed). The most interesting disease in this group is CDG-Ib (phosphomannose isomerase deficiency) because it is so far the only efficiently treatable CDG (mannose treatment). It hasahepatic–intestinal presentation. The O-glycosylation defects comprise two O-xylosylglycan defects (a progeroid variant of Ehlers–Danlos syndrome and the multiple exostoses syndrome) and two O-mannosylglycan defects (Walker–Warburg syndrome and muscle–eye–brain disease). All known CDGs have a recessive inheritance except for multiple exostoses syndrome, which is dominantly inherited. There is a rapidly growing group of putative CDGs with a large spectrum of clinical presentations (CDG-x). Serum transferrin isoelectrofocusing remains the cornerstone of the screening for N-glycosylation defects associated with sialic acid deficiency. Abnormal patterns can be grouped in to type 1 and type 2. However, a normal pattern does not exclude these defects. Screening for the other CDGs is much more difficult, particularly when the defect is organ- or system-restricted. The latter group promises to become an important new chapter in CDG. It is concluded that CDGs will eventually cover the whole clinical spectrum of paediatric and adult disease manifestations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Similar content being viewed by others

REFERENCES

  • Acarregui MJ, George TN, Rhead WJ (1998) Carbohydrate-deficient glycoprotein syndrome type I with profound thrombocytopenia and normal phosphomannomutase and phosphomannose isomerase activities. J Pediatr 133: 697-700.

    Article  PubMed  CAS  Google Scholar 

  • Aebi M, Hennet T (2001) Congenital disorders of glycosylation: genetic model systems lead the way. Trends Cell Biol 11: 136-141.

    Article  PubMed  CAS  Google Scholar 

  • Alton G, Hasilik M, Niehues R, et al (1998) Direct utilization of mannose for mammalian glycoprotein biosynthesis. Glycobiology 8: 285-295.

    Article  PubMed  CAS  Google Scholar 

  • Asano M, Furukawa K, Kido M, et al (1997) Growth retardation and early death of b-1,4-galactosyltransferase knockout mice with augmented proliferation and abnormal differentiation of epithelial cells. EMBO J 16: 1850-1857.

    Article  PubMed  CAS  Google Scholar 

  • Assmann B, Hackler R, Peters V, et al (2001) A new subtype of a congenital disorder of glycosylation (CDG) with mild clinical manifestations. Neuropediatrics 32: 313-318.

    PubMed  CAS  Google Scholar 

  • Barone R, Pavone V, Pennisi P, Fiumara A, Fiore CE (2002) Assessment of skeletal status in patients with congenital disorder of glycosylation type Ia. Int J Tissue React 24: 23-28.

    PubMed  CAS  Google Scholar 

  • Beltrán-Valero de Bernabé D, Currier S, Steinbrecher A, et al (2002) Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet 71: 1033-1043.

    Article  PubMed  Google Scholar 

  • Bhattacharyya R, Bhaumik M, Raju TS, Stanley P (2002) Truncated, inactive N-acetylglucosaminyltransferase III (GlcNAc-TIII) induces neurological and other traits absent in mice that lack Glc-NAc-TIII. J Biol Chem 277: 26300-26309.

    Article  PubMed  CAS  Google Scholar 

  • Briones P, Vilaseca MA, Garcia-Silva MT, et al (2001) Congenital disorders of glycosylation (CDG) may be underdiagnosed when mimicking mitochondrial disease. Eur J Paediatr Neurol 5: 127-131.

    Article  PubMed  CAS  Google Scholar 

  • Brockington M, Blake DJ, Prandini P, et al (2001a) Mutations in the Fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin a2 deficiency and abnormal glycosylation of a-dystroglycan. Am J Hum Genet 69: 1198-1209.

    Article  PubMed  CAS  Google Scholar 

  • Brockington M, Yura Y, Prandini P, et al (2001b) Mutations in the Fukutin related protein gene (FKRP) identifies limb-girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet 10: 2851-2859.

    Article  PubMed  CAS  Google Scholar 

  • Buist N, Grompe M, Steiner R, Miura Y, O'Brien J, Freeze HH (2000) Yet another congenital disorder of glycosylation! (CDGS). J Inherit Metab Dis 23(supplement 1): 187.

    Google Scholar 

  • Burda P, Borsig L, de Rijk-van Andel J, et al (1998) A novel carbohydrate-deficient glycoprotein syndrome characterized by a deficiency in glucosylation of the dolichol-linked oligosaccharide. J Clin Invest 102: 647-652.

    PubMed  CAS  Google Scholar 

  • Burlina AB, Bonafé L, Van Schaftingen E, Jaeken J (2000) Congenital defects of glycosylation with retardation-dysmorphy syndrome and myopathic changes. J Inherit Metab Dis 23(supplement 1): 180.

    Article  Google Scholar 

  • Chantret I, Dancourt J, Dupré T, et al (2002a) A deficiency in dolichyl-P-glucose: Glc1Man9GlcNAc2-PP-dolichyl a3-glucosyltransferase defines a new subtype of congenital disorders of glycosylation (CDG). J Biol Chem. Dec. 11 [e-pub. ahead of print].

  • Chantret I, Dupré T, Delenda C, et al (2002b) Congenital disorders of glycosylation type Ig is defined by a deficiency in dolichyl-P-mannose: Man7GlcNAc2-PP-dolichyl mannosyltransferase. J Biol Chem 277: 25815-25822.

    Article  PubMed  CAS  Google Scholar 

  • Chui D, Sellakumar G, Green RS, et al (2001) Genetic remodeling of protein glycosylation in vivo induces autoimmune disease. Proc Natl Acad Sci USA 98: 1142-1147.

    Article  PubMed  CAS  Google Scholar 

  • Clayton P, Winchester B, di Tomaso E, Young E, Keir G, Rodeck C (1993) Carbohydrate-deficient glycoprotein syndrome: normal glycosylation in the fetus. Lancet 341: 956.

    Article  PubMed  CAS  Google Scholar 

  • Cormand B, Pihko H, Bayes M, et al (2001) Clinical and genetic distinction between Walker-Warburg syndrome and muscle-eye-brain disease. Neurology 56: 1059-1069.

    PubMed  CAS  Google Scholar 

  • Cormier-Daire V, Amiel J, Vuillaumier-Barrot S, et al (2000) Congenital disorders of glycosylation IIa cause growth retardation, mental retardation, and facial dysmorphism. J Med Genet 37: 875 876.

    Article  PubMed  CAS  Google Scholar 

  • de Koning TJ, Dorland J, van Diggelen OP, et al (1998) A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency. Biochem Biophys Res Commun 245: 38-42.

    Article  PubMed  CAS  Google Scholar 

  • de Lonlay P, Cuer M, Vuillaumier-Barrot S, et al (1999) Hyperinsulinemic hypoglycemia as a presenting sign in phosphomannose isomerase deficiency: a new manifestation of carbohydrate deficient glycoprotein syndrome treatablewithmannose. J Pediatr 135: 379-383.

    Article  PubMed  CAS  Google Scholar 

  • de Lonlay P, Seta N, Barrot S, et al (2001) A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases. J Med Genet 38: 14-19.

    Article  PubMed  CAS  Google Scholar 

  • De Praeter CM, Gerwig GJ, Bause E, et al (2000) A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency. Am J Hum Genet 66: 1744-1756.

    Article  PubMed  CAS  Google Scholar 

  • Demetriou M, Granovsky M, Quaggin S, Dennis JW (2001) Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409:733-739.

    Article  PubMed  CAS  Google Scholar 

  • Dorland L, de Koning TJ, Toet M, de Vries LS, van den Berg IET, Poll-Thé BT (1997) Recurrent non-immune hydrops fetalis associated with carbohydrate-deficient glycoprotein syndrome. J Inherit Metab Dis 20(supplement 1): 88.

    Google Scholar 

  • Durand G, Seta N (2000) Protein glycosylation and diseases: blood and urinary oligosaccharides as markers for diagnosis and therapeutic monitoring. Clin Chem 46: 795-805.

    PubMed  CAS  Google Scholar 

  • Eisenberg I, Avidan N, Potikha T, et al (2001) The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nature Genet 29: 83-87.

    Article  PubMed  CAS  Google Scholar 

  • Enns GM, Steiner RD, Buist N, et al (2002) Clinical and molecular features of congenital disorder of glycosylation in patients with type 1 sialotransferrin pattern and diverse ethnic origin. J Pediatr 141: 695-700.

    Article  PubMed  CAS  Google Scholar 

  • Etzioni A, Frydman M, Pollack S, et al (1992) Recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med 327: 1789-1792.

    Article  PubMed  CAS  Google Scholar 

  • Eyskens F, Ceuterick C, Martin JJ, Jansens G, Jaeken J (1994) Carbohydrate-deficient glycoprotein syndrome with previously unreported features. Acta Paediatr 83: 892-896.

    PubMed  CAS  Google Scholar 

  • Fiumara A, Sorge G, Meli C, Barone R, Pavone L (2002) IEF type 1 in COFS/Pena-Shokeir syndrome. A new form of CDG(Ix) with evidence of metabolic defect causing multiple malformations. J Inherit Metab Dis 25 (supplement 1): 134.

    Google Scholar 

  • Fletcher JM, Matthijs G, Jaeken J, Van Schaftingen E, Nelsen PV (2000) Carbohydrate-deficient glycoprotein syndrome: beyond the screen. J Inherit Metab Dis 23: 396-398.

    Article  PubMed  CAS  Google Scholar 

  • Freeze HH (2001) Update and perspectives on congenital disorders of glycosylation. Glycobiology 11: 129R-143R.

    Article  PubMed  CAS  Google Scholar 

  • Freeze HH (2002) Human disorders in N-glycosylation and animal models. Biochim Biophys Acta 1573: 388-393.

    PubMed  CAS  Google Scholar 

  • Garcia Silva MT, Briones P, Schollen E, et al (2002) Congenital disorder of glycosylation (CDG) type IE. A new patient. J Inherit Metab Dis 25 (supplement 1): 133.

    Google Scholar 

  • Grubenmann CE, Frank CG, Kjaergaard S, Berger EG, Aebi M, Hennet T (2002) ALG12 mannosyltransferase defect in congenital disorder of glycosylation type Ig. Hum Mol Genet 11: 2331-2339.

    Article  PubMed  CAS  Google Scholar 

  • Grünewald S, Imbach T, Huijben K, et al (2000) Clinical and biochemical characteristics of congenital disorder of glycosylation type Ic, the first recognized endoplasmic reticulum defect in N-glycan synthesis. Ann Neurol 47: 776-781.

    Article  PubMed  Google Scholar 

  • Grünewald S, Schollen E, Van Schaftingen E, Jaeken J, Matthijs G (2001) High residual acitivity of PMM2 in patients' fibroblasts: possible pitfall in the diagnosis of CDG-Ia phosphomannomutase deficiency). Am J Hum Genet 68: 347-354.

    Article  PubMed  Google Scholar 

  • Grünewald S, Matthijs G, Jaeken J (2002) Congenital disorders of glycosylation: a review. Pediatr Res 52: 618-624.

    Article  PubMed  Google Scholar 

  • Hansske B, Thiel C, Lübke T, et al (2002) Deficiency of UDP-galactose:N-acetylglucosamine b-1,4-galactosyltransferase I causes the congenital disorder of glycosylation type IId. J Clin Invest 109: 725-733.

    Article  PubMed  CAS  Google Scholar 

  • Harms HK, Zimmer KP, Kurnik K, Bertele-Harms RM, Weidinger S, Reiter K (2002) Oral mannose therapy persistently corrects the severe clinical symptoms and biochemical abnormalities of phosphomannose isomerase deficiency. Acta Paediatr 91: 1065-1072.

    Article  PubMed  CAS  Google Scholar 

  • Hayashi YK, Ogawa M, Tagawa K, et al (2001) Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology 57: 115-121.

    PubMed  CAS  Google Scholar 

  • Helenius J, Aebi M (2002) Transmembrane movement of dolichol linked carbohydrates during N-glycoprotein biosynthesis in the endoplasmic reticulum. Semin Cell Dev Biol 13: 171-178.

    Article  PubMed  CAS  Google Scholar 

  • Hendriksz CJ, McClean P, Henderson MJ, et al (2001) Successful treatment of carbohydrate deficient glycoprotein syndrome type 1b with oral mannose. Arch Dis Child 85: 339-340.

    Article  PubMed  CAS  Google Scholar 

  • Hennet T (2002) The galactosyltransferase family. Cell Mol Life Sci 59: 1081-1095.

    Article  PubMed  CAS  Google Scholar 

  • Hinderlich S, Eisenberg I, Horstkorte R, Reutter W, Mitrani-Rosenbaum S (2002) Is hereditary inclusion body myopathy a glycosylation disease? Glycobiology 12: 643.

    Google Scholar 

  • Hirschberg CB, Robbins PW, Abeijon C (1998) Transporters of nucleotide sugars, ATP, and nucleotide sulfate in the endoplasmic reticulum and Golgi apparatus. Annu Rev Biochem 67: 49-69.

    Article  PubMed  CAS  Google Scholar 

  • Huemer M, Huber W-D, Schima W, et al (2000) Budd-Chiari syndrome associated with coagulation abnormalities in a child with carbohydrate deficient glycoprotein syndrome type Ix. J Pediatr 136: 691-695.

    Article  PubMed  CAS  Google Scholar 

  • Imbach T, Schenk B, Schollen E, et al (2000) Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie. J Clin Invest 105: 233-239.

    PubMed  CAS  Google Scholar 

  • Jaeken J, Carchon H(2001) Congenital disorders of glycosylation: the rapidly growing tip of the iceberg. Curr Opin Neurol 14: 811-815.

    Article  PubMed  CAS  Google Scholar 

  • Jaeken J, Matthijs G (2001) Congenital disorders of glycosylation. Annu Rev Genomics Hum Genet 2: 129-151.

    Article  PubMed  CAS  Google Scholar 

  • Jaeken J, Vanderschueren-Lodeweyckx M, Casaer P, et al (1980) Familial psychomotor retardation with markedly fluctuating serum proteins, FSH and GH levels, partial TBG-deficiency, increased serum arylsulphatase A and increased CSF protein: a new syndrome? Pediatr Res 14: 179.

    Google Scholar 

  • Jaeken J, van Eijk HG, van der Heul C, Corbeel L, Eeckels R, Eggermont E (1984) Sialic acid-deficient serum and cerebrospinal fluid transferrin in a newly recognized genetic syndrome. Clin Chim Acta 144: 245-247.

    Article  PubMed  CAS  Google Scholar 

  • Jaeken J, Schachter H, Carchon H, De Cock P, Coddeville B, Spik G (1994) Carbohydrate-deficient glycoprotein syndrome type II: a deficiency in Golgi localised N-acetyl-glucosaminyltransferase II. Arch Dis Child 71: 123-127.

    Article  PubMed  CAS  Google Scholar 

  • Jaeken J, Matthijs G, Saudubray JM, et al (1998) Phosphomannose isomerase deficiency: a carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation. Am J Hum Genet 62: 1535-1539.

    Article  PubMed  CAS  Google Scholar 

  • Jaeken J, Imbach T, Schenk B, et al (2000) A newly recognized glycosylation defect with psychomotor retardation, ichthyosis and dwarfism. J Inherit Metab Dis 23(supplement 1): 186.

    Google Scholar 

  • Jaeken J, Matthijs G, Carchon H, Van Schaftingen E (2001) Defects of N-glycan synthesis. In Scriver CR, Beaudet WS, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 1601-1621.

    Google Scholar 

  • Kano H, Kobayashi K, Herrmann R, et al (2002) Deficiency of a-dystroglycan in muscle-eye-brain disease. Biochem Biophys Res Commun 291: 1283-1286.

    Article  PubMed  CAS  Google Scholar 

  • Kim S, Westphal V, Srikrishna G, et al (2000) Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie). J Clin Invest 105: 191-198.

    PubMed  CAS  Google Scholar 

  • Kjaergaard S, Schwartz M, Skovby F (2001) Congenital disorder of glycosylation type Ia (CDG-Ia): phenotypic spectrum of the R141H/F119L genotype. Arch Dis Child 85: 236-239.

    Article  PubMed  CAS  Google Scholar 

  • Kjaergaard S, Müller J, Skovby F (2002) Prepubertal growth in congenital disorder of glycosylation type Ia (CDG-Ia). Arch Dis Child 87: 324-327.

    Article  PubMed  CAS  Google Scholar 

  • Kobata A (1992) Structures and functions of the sugar chains of glycoproteins. Eur J Biochem 209: 483-501.

    Article  PubMed  CAS  Google Scholar 

  • Körner C, Knauer R, Stephani U, Marquardt T, Lehle L, von Figura K (1999) Carbohydrate deficient glycoprotein syndrome type IV: deficiency of dolichyl-P-Man: Man5GlcNAc2-PP-dolichyl mannosyltransferase. EMBO J 18: 6816-6822.

    Article  PubMed  Google Scholar 

  • Kornfeld R, Kornfeld S (1985) Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 54: 631-664.

    Article  PubMed  CAS  Google Scholar 

  • Kranz C, Denecke J, Lehrman MA, et al (2001a) A mutation in the human MPDU1 gene causes congenital disorder of glycosylation type If (CDG-If). J Clin Invest 108: 1613-1619.

    Article  PubMed  CAS  Google Scholar 

  • Kranz C, Sagi D, Denecke J, et al (2001b) Defective galactosylation in congenital disorder of glycosylation type x (CDG-x). J Inherit Metab Dis 24 (supplement 1): 113.

    Google Scholar 

  • Lammens M (2000) Neuronal migration disorders in man. Eur J Morphol 38: 327-333.

    Article  PubMed  CAS  Google Scholar 

  • Leonard J, Grünewald S, Clayton P (2001) Diversity of congenital disorders of glycosylation. Lancet 357: 1382-1383.

    Article  PubMed  CAS  Google Scholar 

  • Lübke T, Marquardt T, Etzioni A, Hartmann E, von Figura K, Körner C (2001) Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency. Nature Genetics 28: 73-76.

    Article  PubMed  Google Scholar 

  • Lühn K, Wild MK, Eckhardt M, Gerardy-Schahn R, Vestweber D (2001) The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter. Nature Genetics 28: 69-72.

    Article  PubMed  Google Scholar 

  • Marquardt T, Freeze HH (2001) Congenital disorders of glycosylation: glycosylation defects in man and biological models for their study. Biol Chem 382: 161-177.

    Article  PubMed  CAS  Google Scholar 

  • Marquardt T, Hasilik M, Niehues R, et al (1997) Mannose therapy in carbohydrate-deficient glycoprotein syndrome type 1: first results of the German multicenter study. Amino Acids 12: 389.

    Google Scholar 

  • Matthijs G, Schollen E, Pardon E, et al (1997) Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome). Nature Genetics 16: 88-92.

    Article  PubMed  CAS  Google Scholar 

  • Mention K, Michaud L, Dobbelaere D, Guimber D, Gottrand F, Turck D (2001) Neonatal severe intractable diarrhoea as the presenting manifestation of an unclassified congenital disorder of glycosylation (CDG-x). Arch Dis Child Fetal Neonatal Ed 85: F217-F219.

    Article  PubMed  CAS  Google Scholar 

  • Michele DE, Barresi R, Kanagawa M, et al (2002) Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 418: 417-422.

    Article  PubMed  CAS  Google Scholar 

  • Mills P, Mills K, Clayton P, Johnson A, Whitehouse D, Winchester B (2001) Congenital disorders of glycosylation type I leads to altered processing of N-linked glycans, as well as underglycosylation. Biochem J 359: 249-254.

    Article  PubMed  CAS  Google Scholar 

  • Moore SA, Saito F, Chen J, et al (2002) Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature 418: 422-425.

    Article  PubMed  CAS  Google Scholar 

  • Muntoni F, Brockington M, Blake DJ, Torelli S, Brown SC (2002) Defective glycosylation in muscular dystrophy. Lancet 360: 1419-1421.

    Article  PubMed  Google Scholar 

  • Niehues R, Hasilik M, Alton G, et al (1998) Carbohydrate-deficient glycoprotein syndrome type Ib: phosphomannose isomerase deficiency and mannose therapy. J Clin Invest 101: 1414-1420.

    Article  PubMed  CAS  Google Scholar 

  • Okajima T, Fukumoto S, Furukawa K, Urano T, Furukawa K (1999) Molecular basis for the progeroid variant of Ehlers-Danlos syndrome. J Biol Chem 274: 28841-28844.

    Article  PubMed  CAS  Google Scholar 

  • Panneerselvam K, Freeze HH (1996) Mannose corrects altered N-glycosylation in carbohydrate-deficient glycoprotein syndrome fibroblasts. J Clin Invest 97: 1478-1487.

    PubMed  CAS  Google Scholar 

  • Parodi AJ (2000) Protein glucosylation and its role in protein folding. Annu Rev Biochem 69: 69-93.

    Article  PubMed  CAS  Google Scholar 

  • Peters V, Penzien JM, Reiter G, et al (2002) Congenital disorder of glycosylation IId (CDG-IId)-A new entity: clinical presentation with Dandy-Walker malformation and myopathy. Neuropediatrics 33: 27-32.

    Article  PubMed  CAS  Google Scholar 

  • Prietsch V, Peters V, Hackler R, et al (2002) A new case of CDG-x with stereotyped dystonic hand movements and optic atrophy. J Inherit Metab Dis 25: 126-130.

    Article  PubMed  CAS  Google Scholar 

  • Quelhas D, Vilarinho L, Teles EL, et al (2001) Congenital disorders of glycosylation type-x with type 2 pattern of transferrin isolectric focusing. J Inherit Metab Dis 24 (supplement 1): 112.

    Google Scholar 

  • Quentin E, Gladen A, Roden L, Kresse H (1990) A genetic defect in the biosynthesis of dermatan sulfate proteoglycan: galactosyltransferase I deficiency in fibroblasts from a patient with a progeroid syndrome. Proc Natl Acad Sci USA 87: 1342-1346.

    Article  PubMed  CAS  Google Scholar 

  • Ramaekers VT, Stibler H, Kint J, Jaeken J (1991) A new variant of the carbohydrate deficient glycoprotein syndrome. J Inherit Metab Dis 14: 385-388.

    Article  PubMed  CAS  Google Scholar 

  • Ross ME (2002) Full circle to cobbled brain. Nature 418: 376-377.

    Article  PubMed  CAS  Google Scholar 

  • Rudd PM, Elliott T, Creswell P, Wilson IA, Dwek RA (2001) Glycosylation and the immune system. Science 291: 2370-2376.

    Article  PubMed  CAS  Google Scholar 

  • Sala G, Dupré T, Seta N, Codogno P, Ghidoni R (2002) Increased biosynthesis of glycosphingolipids in congenital disorder of glycosylation Ia (CDG-Ia) fibroblasts. Pediatr Res 52: 645-651.

    Article  PubMed  CAS  Google Scholar 

  • Schachter H (1991) The 'yellow brick road' to branched complex N-glycans. Glycobiology 1: 453-461.

    PubMed  CAS  Google Scholar 

  • Schachter H (2001) Congenital disorders involving defective N-glycosylation of proteins. Cell Mol Life Sci 58: 1085-1104.

    Article  PubMed  CAS  Google Scholar 

  • Schenk B, Imbach T, Frank CG, et al (2001) MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If. J Clin Invest 108: 1687-1695.

    Article  PubMed  CAS  Google Scholar 

  • Smith PL, Myers JT, Rogers CE, et al (2002) Conditional control of selectin ligand expression and global fucosylation events in mice with a targeted mutation at the FX locus. J Cell Biol 158: 801-815.

    Article  PubMed  CAS  Google Scholar 

  • Stanley P, Ioffe E (1995) Glycosyltransferase mutants: key to new insights in glycobiology. FASEB J 9: 1436-1444.

    PubMed  CAS  Google Scholar 

  • Stibler H, Stephani U, Kutsch U (1995) Carbohydrate-deficient glycoprotein syndrome: a fourth subtype. Neuropediatrics 26: 235-237.

    Article  PubMed  CAS  Google Scholar 

  • Stibler H, Gylje H, Uller A (1999) A neurodystrophic syndrome resembling carbohydrate-deficient glycoprotein syndrome type III. Neuropediatrics 30: 90-92.

    PubMed  CAS  Google Scholar 

  • Sturla P, Puglielli L, Tonetti M, et al (2001) Impairment of the Golgi GDP-L-fucose transport and unresponsiveness to fucose replacement therapy in LADII patients. Pediatr Res 49: 537-542.

    PubMed  CAS  Google Scholar 

  • Sturla L, Rampal R, Haltiwanger RS, Zanardi D, Etzioni A, Tonetti M(2002) Characterization of the residual fucose-containing glycoconjugates in LADII/CDGS IIc cells. Glycobiology 12: 664.

    Google Scholar 

  • Subhedar NV, Isherwood DM, Davidson DC (1996) Hyperglycinaemia in a child with carbohydrate-deficient glycoprotein syndrome type I. J Inherit Metab Dis 19: 796-797.

    Article  PubMed  CAS  Google Scholar 

  • Thiel C, Schwarz M, Hasilik M, et al (2002) Deficiency of dolichyl-P-Man: Man7GlcNAc2-PP-dolichyl mannosyltransferase causes congenital disorder of glycosylation type Ig. Biochem J 367: 195-201

    Article  PubMed  CAS  Google Scholar 

  • Van den Steen P, Rudd PM, Dwek RA, Opdenakker G (1998) Concepts and principles of O-linked glycosylation. Crit Rev Biochem Mol Biol 33: 151 208.

    Article  PubMed  CAS  Google Scholar 

  • Van Dijk W, Koeleman C, Van het Hof B, Poland D, Jakobs C, Jaeken J (2001) Increased a3-fucosylation of a1-acid glycoprotein in patients with congenital disorder of glycosylation type IA (CDG-Ia). FEBS Lett 494: 232-235.

    Article  PubMed  CAS  Google Scholar 

  • van Eijk HG, Van Noort WL, Dubelaar M-L, Van der Heul C (1983) The microheterogeneity of human transferrins in biological fluids. Clin Chim Acta 132: 167-171.

    Article  PubMed  CAS  Google Scholar 

  • Van Geet C, Jaeken J, Freson K, et al (2001) Congenital disorders of glycosylation Ia and IIa are associated with different primary haemostatic complications. J Inherit Metab Dis 24: 477-492.

    Article  PubMed  CAS  Google Scholar 

  • Van Maldergem L, Jaeken J (2001) Two siblings with severe mental retardation, facial dysmorphia and ectopic kidneys and a type 2 pattern of serum sialotransferrin isoelectrofocusing. J Inherit Metab Dis 24: (supplement 1): 112.

    Google Scholar 

  • Van Schaftingen E, Jaeken J (1995) Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I. FEBS Lett 377: 318-320.

    Article  PubMed  CAS  Google Scholar 

  • Varki A (1993) Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 3: 97-130.

    PubMed  CAS  Google Scholar 

  • Varki A, Marth J (1995) Oligosaccharides in vertebrate development. Dev Biol 6: 127-138.

    Article  CAS  Google Scholar 

  • Völker C, De Praeter CM, Hardt B, et al (2002) Processing of N-linked carbohydrate chains in a patient with glucosidase I deficiency (CDG type IIb). Glycobiology 12: 473-483.

    Article  PubMed  Google Scholar 

  • Wada Y, Nishikawa A, Okamoto N, et al (1992) Structure of serum transferrin in carbohydrate-deficient glycoprotein syndrome. BiochemBiophys Res Commun 189: 832-836.

    Article  CAS  Google Scholar 

  • Wang Y, Tan J, Sutton-Smith M, et al (2001) Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis. Glycobiology 11: 1051-1070.

    Article  PubMed  CAS  Google Scholar 

  • Westphal V, Kjaergaard S, Davis JA, Peterson SM, Skovby F, Freeze HH (2001) Genetic and metabolic analysis of the first adult with congenital disorder of glycosylation type Ib: long-term outcome and effects of mannose supplementation. Mol Genet Metab 73: 77-85.

    Article  PubMed  CAS  Google Scholar 

  • Wicklund CL, Pauli RM, Johnston D, Hecht JT (1995) Natural history study of hereditary multiple exostoses. Am J Med Genet 55: 43-46.

    Article  PubMed  CAS  Google Scholar 

  • Willer T, Amselgruber W, Deutzmann R, Strahl S (2002) Characterization of POMT2, a novel member of the PMT protein O-mannosyltransferase family specifically localized to the acrosome of mammalian spermatids. Glycobiology 12: 771-783.

    Article  PubMed  CAS  Google Scholar 

  • Wuyts W, Van Hul W(2000) Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes. Hum Mutat 15: 220-227.

    Article  PubMed  CAS  Google Scholar 

  • Yamashita K, Ohkura T, Ideo H, Ohno K, Kanai M (1993) Electrospray ionization mass spectrometric analysis of serum transferrin isoforms in patients with carbohydrate-deficient glycoprotein syndrome. J Biochem 114: 766-769.

    PubMed  CAS  Google Scholar 

  • Yoshida A, Kobayashi K, Manya H, et al (2001) Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev Cell 1: 717-724.

    Article  PubMed  CAS  Google Scholar 

  • Zak BM, Crawford BE, Esko JD (2002) Hereditary multiple exostoses and heparan sulfate polymerisation. Biochim Biophys Acta 1573: 346-355.

    PubMed  CAS  Google Scholar 

  • Zdebska E, Golaszewska E, Fabijanska-Mitek J, et al (2001a) Glycoconjugate abnormalities in patients with congenital dyserythropoietic anemia type I, II and III. Br J Haematol 114: 907-913.

    Article  PubMed  CAS  Google Scholar 

  • Zdebska E, Musielak M, Jaeken J, Kościelak J (2001b) Band 3 glycoprotein and glycophorin A from erythrocytes of children with congenital disorder of glycosylation type-Ia are underglycosylated. Proteomics 1: 269-274.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Centre for Metabolic Disease, University Hospital Gasthuisberg, Herestraat 49, B-3000, Leuven, Belgium

    J. Jaeken

Authors
  1. J. Jaeken
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jaeken, J. Congenital disorders of glycosylation (CDG): It's all in it!. J Inherit Metab Dis 26, 99–118 (2003). https://doi.org/10.1023/A:1024431131208

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1024431131208

Keywords

Search

Navigation